Concurrent chemoradiotherapy with low-dose weekly platinum agent for head and neck carcinoma

Clin Otolaryngol. 2020 Nov;45(6):952-955. doi: 10.1111/coa.13623. Epub 2020 Sep 17.

Authors

Masayuki Kitano^{1

2}, Tsuyoshi Kojima¹, Yusuke Okanoue¹, Shintaro Fujimura², Seiji Oyagi², Kazuhiko Shoji¹, Ryusuke Hori¹

Affiliations

¹ Department of Otolaryngology, Tenri Hospital, Nara, Japan.
² Department of Otolaryngology-Head & Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

PMID: 32741125
DOI: 10.1111/coa.13623

No abstract available

Keywords: chemo-radiotherapy; head and neck cancer; hypopharynx; larynx; oncology; oropharynx.

Publication types

Letter

MeSH terms

Aged
Antineoplastic Agents / administration & dosage*
Chemoradiotherapy*
Cisplatin / administration & dosage*
Female
Head and Neck Neoplasms / drug therapy
Head and Neck Neoplasms / mortality
Head and Neck Neoplasms / pathology
Head and Neck Neoplasms / therapy*
Humans
Male
Middle Aged
Neoplasm Staging
Retrospective Studies
Survival Rate

Substances

Antineoplastic Agents
Cisplatin